New technologies are needed to enable the molecular characterization of the complex relationship between the immune system and cancer. This proposal aims to apply a novel approach to high-dimensional analysis of cancer samples, in order to determine if it can help to elucidate the interactions between the immune system and cancers, and ultimately to correlate these effects with outcome.

Public Health Relevance

The interaction of the immune system and cancer is important to outcome but is poorly understood. We are developing a more powerful way to analyze this complex interaction. If successful, this project may enable improvements in the molecular analysis and treatment of cancer.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Small Business Innovation Research Grants (SBIR) - Phase I (R43)
Project #
1R43CA186595-01
Application #
8715536
Study Section
Special Emphasis Panel (ZRG1-OTC-H (13))
Program Officer
Weber, Patricia A
Project Start
2014-08-18
Project End
2015-02-17
Budget Start
2014-08-18
Budget End
2015-02-17
Support Year
1
Fiscal Year
2014
Total Cost
$225,000
Indirect Cost
Name
Prognosys Biosciences, Inc.
Department
Type
DUNS #
170943737
City
San Diego
State
CA
Country
United States
Zip Code
92121